Sage Rhino Capital’s Novartis NVS Stock Holding History

Sage Rhino Capital's NVS Position: Q2 2026 in Review

Sage Rhino Capital increased its Novartis (NVS) stake by 3.9% in Q2 2026, buying an estimated $45.1K and bringing the position to 7,947 shares worth $1.25M. The position accounts for 0.2% of the portfolio, ranked #90.

Sage Rhino Capital first reported a position in NVS in Q1 2019 and has held it in 30 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

• Sage Rhino Capital held 7,947 shares of Novartis worth $1.25M as of Q2 2026.
• Sage Rhino Capital bought 301 Novartis shares in Q2 2026, an estimated $45.1K.
• Novartis made up 0.2% of Sage Rhino Capital's portfolio in Q2 2026, its #90 holding.
• Sage Rhino Capital first reported a position in Novartis in Q1 2019 and has held it in 30 quarters since.
• 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.